Sigma-Aldrich acquires Research Organics, strengthens PharmaGrade raw materials portfolio
Sigma-Aldrich Corporation says it has acquired all outstanding shares of Cleveland, Ohio-based, Research Organics, Inc., to expand the Company''s buffer production capacity and to increase its portfolio of PharmaGrade raw materials for the biopharmaceutical and diagnostic markets. Research Organics is a leading supplier of high purity biochemicals for use in molecular biology, diagnostics, cell culture, pharmaceuticals, biopharmaceuticals, life sciences and biotechnology and will transition into SAFC, the custom manufacturing and services business unit of Sigma-Aldrich.
"Research Organics is an important addition to our pharmaceutical grade portfolio of raw materials for the biopharmaceutical industry," Gilles Cottier, EVP, Sigma-Aldrich, and president, SAFC, says. "This acquisition is an outstanding complement to our existing raw materials portfolio and will help us provide more innovative solutions for some of our customers'' toughest supply challenges. It will also enable us to provide SAFC''s customers with true dual sourcing of buffers from two of the world''s leading manufacturing sites."
Founded in the 1950''s, Research Organics was a pioneer in manufacturing zwitterionic biological buffers and developing the HEPES buffer as an industry-standard.
"Joining Sigma-Aldrich is positive for Research Organics, our employees, customers and the city of Cleveland," Rob Sternfeld, president of Research Organics, says. "The acquisition provides the resources to expand the growth of our business, to enhance our product line and to upgrade our facilities to meet ever changing industry requirements. We will continue to provide our customers with the superior quality and service they deserve and have come to expect."
Terms of the purchase were not disclosed. The Company expects this acquisition to be neutral to earnings per share in 2012.